NDC 81927-204 – Jylamvo

Methotrexate 2 mg/mL · Solution · Oral

Human Prescription Drug

Product NDC81927-204

Product details

Brand name
Jylamvo
Generic name
Methotrexate
Labeler
SHORLA ONCOLOGY INC.
Dosage form
Solution
Route
Oral
Marketing category
NDA · NDA212479
Marketed since
December 15, 2023
Listing expires
December 31, 2027
Pharmacologic class
Folate Analog Metabolic Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Jylamvo →

Package NDC codes (1)

Package NDCDescriptionSince
81927-204-011 BOTTLE, GLASS in 1 CARTON (81927-204-01) / 60 mL in 1 BOTTLE, GLASSDec 15, 2023